Glenmark Pharmaceuticals Archives

Glenmark Pharma Shares Soared 7% on Successfully Clearing USFDA Inspection

Ali WaghbakriwalaSeptember 23, 2024September 23, 2024

by Ali WaghbakriwalaSeptember 23, 2024September 23, 20241970

Shares of Glenmark Pharmaceuticals Ltd soared 7% on 23 September after the company’s manufacturing facility in Aurangabad successfully cleared the US Food and Drug Administration’s...

BUSINESS

Glenmark Receives USFDA Final Approval for Topiramate Capsules

Ali WaghbakriwalaJuly 17, 2024July 17, 2024

by Ali WaghbakriwalaJuly 17, 2024July 17, 202411003

Glenmark Pharmaceuticals has received final approval from the United States Food & Drug Administration (USFDA) for its Topiramate Capsules USP, 15 mg and 25 mg,...

MARKETS

Glenmark Pharma’s Shares Surge as Unit bags Licensing pact to sell Cancer Drugs

Chinmay BohraJanuary 25, 2024January 25, 2024

by Chinmay BohraJanuary 25, 2024January 25, 202418557

Glenmark Pharmaceuticals shares climbed more than 2% in the early trading hours on Thursday after the pharma company announced that its subsidiary, Glenmark Specialty S...

MARKETS

Glenmark Shares Surge as USFDA Grants Approval for Generic Drug Used to Treat Certain Mental Disorders

Chinmay BohraNovember 7, 2023November 7, 2023

by Chinmay BohraNovember 7, 2023November 7, 202308112

Shares of Glenmark Pharmaceuticals Ltd rallied over 2% as the company received final approval from the United States Food & Drug Administration (US FDA) for...

BUSINESS

Glenmark Announces the Launch of Combination Diabetes Drug

Ali WaghbakriwalaOctober 18, 2023October 18, 2023

by Ali WaghbakriwalaOctober 18, 2023October 18, 202301611

Pharmaceutical major Glenmark Pharma, on 18 October, announced the launch of a Triple-drug FDC (fixed drug combination) of Teneligliptin + Dapagliflozin + Metformin in India...

BUSINESS

Glenmark Pharmaceuticals Gets USFDA Approval to Market its Drug

Ali WaghbakriwalaAugust 1, 2023August 1, 2023

by Ali WaghbakriwalaAugust 1, 2023August 1, 2023012967

The Mumbai-based drug maker Glenmark Pharmaceuticals on 1 August said it had received the nod from the US Food and Drug Administration (USFDA) to market...

HEALTHCARE

Glenmark Pharma Signs Settlement Agreement with Pfizer Over Cancer Drug

NileshNovember 22, 2022November 22, 2022

by NileshNovember 22, 2022November 22, 202202418

On Tuesday, Glenmark Pharmaceuticals said it had reached a settlement with Pfizer over a cancer treatment drug.The Mumbai-based drugmaker and its US subsidiary signed a...

MARKETS

Nifty Drops Below 18,250 Level

Neha VermaNovember 18, 2022November 18, 2022

by Neha VermaNovember 18, 2022November 18, 202201694

In the domestic market, barometers extended losses and hit fresh trade low in the morning trade. The Nifty traded tad below the 18,250 level. Also,...

HEALTHCARE

Glenmark Pharma Launches Drug to Treat Type 2 Diabetes in Adults

NileshOctober 6, 2022

by NileshOctober 6, 202201529

Glenmark Pharmaceuticals announced on October 6 that it had become the first company in India to launch thiazolidinedione (lobeglitazone) for adults with type 2 diabetes....

BUSINESS

Glenmark Pharma Launches Ryaltris Nasal Spray for Allergic Rhinitis in US Market

Aniruddh ShrivastavaAugust 31, 2022August 31, 2022

by Aniruddh ShrivastavaAugust 31, 2022August 31, 202201425

US arm of Glenmark Pharmaceuticals has launched the fixed-dose combination (FDC) therapy for seasonal allergic rhinitis in the US market. This Ryaltris nasal spray will...

Download Unicorn Signals App

EquityPandit

Tag : Glenmark Pharmaceuticals

Glenmark Pharma Shares Soared 7% on Successfully Clearing USFDA Inspection

Glenmark Receives USFDA Final Approval for Topiramate Capsules

Glenmark Pharma’s Shares Surge as Unit bags Licensing pact to sell Cancer Drugs

Glenmark Shares Surge as USFDA Grants Approval for Generic Drug Used to Treat Certain Mental Disorders

Glenmark Announces the Launch of Combination Diabetes Drug

Glenmark Pharmaceuticals Gets USFDA Approval to Market its Drug

Glenmark Pharma Signs Settlement Agreement with Pfizer Over Cancer Drug

Nifty Drops Below 18,250 Level

Glenmark Pharma Launches Drug to Treat Type 2 Diabetes in Adults

Glenmark Pharma Launches Ryaltris Nasal Spray for Allergic Rhinitis in US Market

EquityPandit